For purchasing or obtaining a quotation, please visit the Distributor page
to find your local distributor.
to find your local distributor.
HOME > Product search results
Searched by
MHC Allele - A*02:01
Product（484）
[-] MHC tetramer（484）
>Class I（484）
Refine your search
[+]Animal species
[+]Category
[+]Conjugate
[+]MHC Allele
[+]Research area
[+]Tools
[+]Brands
[+]Availability (in Japan)
| Clip | Code No. | Product | Data | |||
|---|---|---|---|---|---|---|
| Data
Sheet |
Category | Conjugate | MHC Allele | Size | Availability | |
| Sequence | Location (aa) | Storage
temp. |
||||
|
|
||||||
|
TS-M072-4 |
HLA-A*02:01 MAGE-A2 Tetramer-YLQLVFGIEV-BV421 |
|
|||
|
cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| YLQLVFGIEV | 157-166 | ４°C | ||||
|
|
TS-M057-4 |
HLA-A*02:01 CMV IE1 316-324 Tetramer-VLEETSVML-BV421 |
|
|||
|
|
virus | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| VLEETSVML | 316-324 | ４°C | ||||
|
|
TC-0107-2 |
HLA-A*02:01 IGRP Tetramer-LNIDLLWSV-APC |
|
|||
|
|
Others | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| LNIDLLWSV | ４°C | |||||
|
|
TC-0153-1 |
HLA-A*02:01 MUC1 Tetramer-LLLTVLTVV-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| LLLTVLTVV | 13-21 | ４°C | ||||
|
|
TC-0165-2 |
HLA-A*02:01 Influenza M1 Tetramer-ILGFVFTLTV-APC |
|
|||
|
|
virus | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| ILGFVFTLTV | ４°C | |||||
|
|
TC-0131-2 |
HLA-A*02:01 EBV BALF4 Tetramer-FLDKGTYTL-APC |
|
|||
|
|
virus | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| FLDKGTYTL | 276-284 | ４°C | ||||
|
|
TC-0154-1 |
HLA-A*02:01 HHV-8 gB Tetramer-LMWYELSKI-PE |
|
|||
|
|
virus | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| LMWYELSKI | ４°C | |||||
|
|
TC-0157-2 |
HLA-A*02:01 p53 Tetramer-RMPEAAPPV-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| RMPEAAPPV | 65-73 | ４°C | ||||
|
|
TS-0019-4C |
HLA-A*02:01 Tyrosinase Tetramer-YMDGTMSQV-BV421 |
|
|||
|
|
cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| YMDGTMSQV | ４°C | |||||
|
|
TC-0174-2 |
HLA-A*02:01 SARS-CoV-2 Spike Glycoprotein Tetramer-RLNEVAKNL-APC |
|
|||
|
|
virus | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| RLNEVAKNL | ４°C | |||||
|
|
TC-0177-4 |
HLA-A*02:01 SARS-CoV-2 Spike Glycoprotein Tetramer-RLQSLQTYV-BV421 |
|
|||
|
|
virus | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| RLQSLQTYV | ４°C | |||||
|
|
TS-M039-2 |
HLA-A*02:01 HCV NS3 1073-1081 Tetramer-CINGVCWTV-APC |
|
|||
|
|
virus | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| CINGVCWTV | 1073-1081 | ４°C | ||||
|
|
TS-0015-4C |
HLA-A*02:01 Her-2/neu E75 Tetramer-KIFGSLAFL-BV421 |
|
|||
|
|
cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| KIFGSLAFL | 369-377 | ４°C | ||||
|
|
TS-M051-4 |
HLA-A*02:01 HBV env 335-343 Tetramer-WLSLLVPFV-BV421 |
|
|||
|
|
virus | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| WLSLLVPFV | 335-343 | ４°C | ||||
|
|
TC-0136-1 |
HLA-A*02:01 p53 Tetramer-GLAPPQHLIRV-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| GLAPPQHLIRV | 187-197 | ４°C | ||||
|
|
TC-0155-4 |
HLA-A*02:01 Survivin Tetramer-LTLGEFLKL-BV421 |
|
|||
|
|
cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| LTLGEFLKL | 96-104 | ４°C | ||||
|
|
TS-0031-2 |
HLA-A*02:01 HPV16 E7 Tetramer-YMLDLQPET-APC |
|
|||
|
|
virus | APC | A*02:01 | 50 tests | 1-9 | |
| YMLDLQPET | 11-19 | ４°C | ||||
|
|
TC-0122-1 |
HLA-A*02:01 HBV S protein Tetramer-FLLTRILTI-PE |
|
|||
|
|
virus | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| FLLTRILTI | ４°C | |||||
|
|
TC-0175-4 |
HLA-A*02:01 SARS-CoV-2 Spike Glycoprotein Tetramer-KLPDDFTGCV-BV421 |
|
|||
|
|
virus | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| KLPDDFTGCV | ４°C | |||||
|
|
TS-0012-4C |
HLA-A*02:01 Influenza-M1 Tetramer-GILGFVFTL-BV421 |
|
|||
|
|
virus | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| GILGFVFTL | ４°C | |||||
|
|
TS-M040-2 |
HLA-A*02:01 HCV NS3 1406-1415 Tetramer-KLVALGINAV-APC |
|
|||
|
|
virus | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| KLVALGINAV | 1406-1415 | ４°C | ||||
|
|
TC-0154-2 |
HLA-A*02:01 HHV-8 gB Tetramer-LMWYELSKI-APC |
|
|||
|
|
virus | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| LMWYELSKI | ４°C | |||||
|
|
TC-0159-4 |
HLA-A*02:01 p53 Tetramer-SLPPPGTRV-BV421 |
|
|||
|
|
cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| SLPPPGTRV | 149-157 | ４°C | ||||
|
|
TC-0120-1 |
HLA-A*02:01 gp100 Tetramer-YLEPGPVTV-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| YLEPGPVTV | ４°C | |||||
|
|
TC-0157-4 |
HLA-A*02:01 p53 Tetramer-RMPEAAPPV-BV421 |
|
|||
|
|
cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| RMPEAAPPV | 65-73 | ４°C | ||||
|
|
TS-M027-4 |
HLA-A*02:01 HIV gag Tetramer-SLYNTVATL-BV421 |
|
|||
|
|
virus | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| SLYNTVATL | 77-85 | ４°C | ||||
|
|
TC-0128-1 |
HLA-A*02:01 hTERT Tetramer-ALLTSRLRFI-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| ALLTSRLRFI | 615-624 | ４°C | ||||
|
|
TC-0131-1 |
HLA-A*02:01 EBV BALF4 Tetramer-FLDKGTYTL-PE |
|
|||
|
|
virus | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| FLDKGTYTL | 276-284 | ４°C | ||||
|
|
TC-0164-1 |
HLA-A*02:01 EZH2 Tetramer-YMCSFLFNL-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| YMCSFLFNL | 666-674 | ４°C | ||||
|
|
TC-0113-4 |
HLA-A*02:01 hTERT Tetramer-YLFFYRKSV-BV421 |
|
|||
|
|
cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| YLFFYRKSV | ４°C | |||||
|
|
TS-0016-2 |
HLA-A*02:01 Her-2/neu Tetramer-RLLQETELV-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| RLLQETELV | 689-697 | ４°C | ||||
|
|
TC-0131-4 |
HLA-A*02:01 EBV BALF4 Tetramer-FLDKGTYTL-BV421 |
|
|||
|
|
virus | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| FLDKGTYTL | 276-284 | ４°C | ||||
|
|
TS-M043-4 |
HLA-A*02:01 HCV NS5B 2594-2602 Tetramer-ALYDVVSKL-BV421 |
|
|||
|
|
virus | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| ALYDVVSKL | 2594-2602 | ４°C | ||||
|
|
TC-0118-1 |
HLA-A*02:01 HCV NS3 1073-1081 Tetramer-CVNGVCWTV-PE |
|
|||
|
|
virus | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| CVNGVCWTV | ４°C | |||||
|
|
TC-0175-1 |
HLA-A*02:01 SARS-CoV-2 Spike Glycoprotein Tetramer-KLPDDFTGCV-PE |
|
|||
|
|
virus | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| KLPDDFTGCV | ４°C | |||||
|
|
TC-0156-4 |
HLA-A*02:01 LIVIN Tetramer-QLCPICRAPV-BV421 |
|
|||
|
|
cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| QLCPICRAPV | 175-184 | ４°C | ||||
|
|
TC-0161-1 |
HLA-A*02:01 PSMA Tetramer-VLAGGFFLL-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| VLAGGFFLL | 27-38 | ４°C | ||||
|
|
TC-0114-2 |
HLA-A*02:01 hTERT Tetramer-YLQVNSLQTV-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| YLQVNSLQTV | ４°C | |||||
|
|
TS-M070-4 |
HLA-A*02:01 MAGE-A1 Tetramer-KVLEYVIKV-BV421 |
|
|||
|
|
cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| KVLEYVIKV | 278-286 | ４°C | ||||
|
|
TS-0016-4 |
HLA-A*02:01 Her-2/neu Tetramer-RLLQETELV-BV421 |
|
|||
|
|
cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| RLLQETELV | 689-697 | ４°C | ||||
|
|
TC-0114-4 |
HLA-A*02:01 hTERT Tetramer-YLQVNSLQTV-BV421 |
|
|||
|
|
cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| YLQVNSLQTV | ４°C | |||||
|
|
TC-0146-1 |
HLA-A*02:01 EBV LMP1 Tetramer-YLLEMLWRL-PE |
|
|||
|
|
virus | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| YLLEMLWRL | 125-133 | ４°C | ||||
|
|
TC-0159-1 |
HLA-A*02:01 p53 Tetramer-SLPPPGTRV-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| SLPPPGTRV | 149-157 | ４°C | ||||
|
|
TC-0113-1 |
HLA-A*02:01 hTERT Tetramer-YLFFYRKSV-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| YLFFYRKSV | ４°C | |||||
|
|
TC-0128-2 |
HLA-A*02:01 hTERT Tetramer-ALLTSRLRFI-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| ALLTSRLRFI | 615-624 | ４°C | ||||
|
|
TC-0133-4 |
HLA-A*02:01 HTLV bZIP Tetramer-AVLDGLLSL-BV421 |
|
|||
|
|
virus | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| AVLDGLLSL | 42-50 | ４°C | ||||
|
|
TS-M040-4 |
HLA-A*02:01 HCV NS3 1406-1415 Tetramer-KLVALGINAV-BV421 |
|
|||
|
|
virus | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| KLVALGINAV | 1406-1415 | ４°C | ||||
|
|
TS-M039-1 |
HLA-A*02:01 HCV NS3 1073-1081 Tetramer-CINGVCWTV-PE |
|
|||
|
|
virus | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| CINGVCWTV | 1073-1081 | ４°C | ||||
|
|
TC-0121-1 |
HLA-A*02:01 LCMV ND Tetramer-ALPHIIDEV-PE |
|
|||
|
|
virus | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| ALPHIIDEV | ４°C | |||||
|
|
TC-0132-1 |
HLA-A*02:01 topo II Tetramer-FLYDDNQRV-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| FLYDDNQRV | 828-836 | ４°C | ||||
|
|
TC-0135-4 |
HLA-A*02:01 HIV Vif Tetramer-GLADQLIHL-BV421 |
|
|||
|
|
virus | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| GLADQLIHL | 101-109 | ４°C | ||||
|
|
TC-0127-2 |
HLA-A*02:01 PSCA Tetramer-AILALLPAL-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| AILALLPAL | 105-133 | ４°C | ||||
|
|
TC-0132-2 |
HLA-A*02:01 topo II Tetramer-FLYDDNQRV-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| FLYDDNQRV | 828-836 | ４°C | ||||
|
|
TS-M082-2 |
HLA-A*02:01 gp100 Tetramer-YLEPGPVTA-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| YLEPGPVTA | 280-288 | ４°C | ||||
|
|
TC-0153-2 |
HLA-A*02:01 MUC1 Tetramer-LLLTVLTVV-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| LLLTVLTVV | 13-21 | ４°C | ||||
|
|
TC-0121-2 |
HLA-A*02:01 LCMV ND Tetramer-ALPHIIDEV-APC |
|
|||
|
|
virus | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| ALPHIIDEV | ４°C | |||||
|
|
TS-M072-2 |
HLA-A*02:01 MAGE-A2 Tetramer-YLQLVFGIEV-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| YLQLVFGIEV | 157-166 | ４°C | ||||
|
|
TS-M076-2 |
HLA-A*02:01 MAGE-A3 271-279 Tetramer-FLWGPRALV-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests | 1-9 | |
| FLWGPRALV | 271-279 | ４°C | ||||
|
|
TC-0110-2 |
HLA-A*02:01 Mesothelin Tetramer-SLLFLLFSL-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| SLLFLLFSL | ４°C | |||||
|
|
TS-M107-4 |
HLA-A*02:01 PAP 299-307 Tetramer-ALDVYNGLL-BV421 |
|
|||
|
|
cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| ALDVYNGLL | 299-307 | ４°C | ||||
|
|
TC-0135-2 |
HLA-A*02:01 HIV Vif Tetramer-GLADQLIHL-APC |
|
|||
|
|
virus | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| GLADQLIHL | 101-109 | ４°C | ||||
|
|
TC-0164-4 |
HLA-A*02:01 EZH2 Tetramer-YMCSFLFNL-BV421 |
|
|||
|
|
cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| YMCSFLFNL | 666-674 | ４°C | ||||
|
|
TC-0150-1 |
HLA-A*02:01 hTERT Tetramer-GLLGASVLGL-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| GLLGASVLGL | 674-683 | ４°C | ||||
|
|
TC-0159-2 |
HLA-A*02:01 p53 Tetramer-SLPPPGTRV-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| SLPPPGTRV | 149-157 | ４°C | ||||
|
|
TC-8006-1 |
HLA-A*02:01 P53168-176 R175H Tetramer-HMTEVVRHC-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| HMTEVVRHC | 168-176 | ４°C | ||||
|
|
TC-8006-2 |
HLA-A*02:01 P53168-176 R175H Tetramer-HMTEVVRHC-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| HMTEVVRHC | 168-176 | ４°C | ||||
|
|
TC-8010-2 |
HLA-A*02:01 KRAS5-14 G12D Tetramer-KLVVVGADGV-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| KLVVVGADGV | 5-14 | ４°C | ||||
|
|
TC-8010-1 |
HLA-A*02:01 KRAS5-14 G12D Tetramer-KLVVVGADGV-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| KLVVVGADGV | 5-14 | ４°C | ||||
|
|
TS-M243-1 |
HLA-A*02:01 UGCGL2 Neoepitope Tetramer-GLLDEDFYA-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| GLLDEDFYA | ４°C | |||||
|
|
TS-M247-2 |
HLA-A*02:01 AGMO Neoepitope Tetramer-ALLQVTLLL-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| ALLQVTLLL | ４°C | |||||
|
|
TS-M250-2 |
HLA-A*02:01 EBV BRLF1 Tetramer-YVLDHLIVV-APC |
|
|||
|
|
virus | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| YVLDHLIVV | 109-117 | ４°C | ||||
|
|
TS-M246-1 |
HLA-A*02:01 GOLGA3 Neoepitope Tetramer-SLDLTTSPV-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| SLDLTTSPV | ４°C | |||||
|
|
TC-8017-1 |
HLA-A*02:01 AFP158-166 Tetramer-FMNKFIYEI-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| FMNKFIYEI | 158-166 | ４°C | ||||
|
|
TC-8013-1 |
HLA-A*02:01 KRAS5-14 G12C Tetramer-KLVVVGACGV-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| KLVVVGACGV | 5-14 | ４°C | ||||
|
|
TS-M241-1 |
HLA-A*02:01 CK1α Neoepitope Tetramer-GLFGDIYLA-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| GLFGDIYLA | ４°C | |||||
|
|
TS-M230-1 |
HLA-A*02:01 USP28 Neoepitope Tetramer-LIIPFIHLI-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| LIIPFIHLI | ４°C | |||||
|
|
TS-M230-2 |
HLA-A*02:01 USP28 Neoepitope Tetramer-LIIPFIHLI-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| LIIPFIHLI | ４°C | |||||
|
|
TC-8009-2 |
HLA-A*02:01 MAGE-A4286-294 Tetramer-KVLEHVVRV-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| KVLEHVVRV | 286-294 | ４°C | ||||
|
|
TC-8007-2 |
HLA-A*02:01 P53168-176 Tetramer-HMTEVVRRC-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| HMTEVVRRC | 168-176 | ４°C | ||||
|
|
TS-M217-2 |
HLA-A*02:01 ME3 Neoepitope Tetramer-FLDEFMEGV-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| FLDEFMEGV | ４°C | |||||
|
|
TC-8011-1 |
HLA-A*02:01 KRAS5-14 G12V Tetramer-KLVVVGAVGV-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| KLVVVGAVGV | 5-14 | ４°C | ||||
|
|
TC-8019-2 |
HLA-A*02:01 MAGE-A2112-120 Tetramer-KMVELVHFL-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| KMVELVHFL | 112-120 | ４°C | ||||
|
|
TS-M247-1 |
HLA-A*02:01 AGMO Neoepitope Tetramer-ALLQVTLLL-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| ALLQVTLLL | ４°C | |||||
|
|
TS-M225-1 |
HLA-A*02:01 Hsp70 Neoepitope Tetramer-SLFEGIDIYT-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| SLFEGIDIYT | ４°C | |||||
|
|
TC-8017-2 |
HLA-A*02:01 AFP158-166 Tetramer-FMNKFIYEI-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| FMNKFIYEI | 158-166 | ４°C | ||||
|
|
TS-M248-2 |
HLA-A*02:01 Insulin Tetramer-ALWGPDPAAA-APC |
|
|||
|
|
Others | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| ALWGPDPAAA | 15-24 | ４°C | ||||
|
|
TS-M234-2 |
HLA-A*02:01 GAS7 Neoepitope Tetramer-SLADEAEVYL-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| SLADEAEVYL | ４°C | |||||
|
|
TS-M239-1 |
HLA-A*02:01 SPOP Neoepitope Tetramer-FLLDEAIGL-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| FLLDEAIGL | ４°C | |||||
|
|
TS-M246-2 |
HLA-A*02:01 GOLGA3 Neoepitope Tetramer-SLDLTTSPV-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| SLDLTTSPV | ４°C | |||||
|
|
TS-M211-2 |
HLA-A*02:01 HER2 Neoepitope Tetramer-ALIHHNTYL-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| ALIHHNTYL | ４°C | |||||
|
|
TS-M208-2 |
HLA-A*02:01 p53 Neoepitope Tetramer-VVPCEPPEV-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| VVPCEPPEV | ４°C | |||||
|
|
TS-M203-2 |
HLA-A*02:01 HPV16 E7 Tetramer-LLMGTLGIV-APC |
|
|||
|
|
virus | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| LLMGTLGIV | 82-90 | ４°C | ||||
|
|
TC-8020-1 |
HLA-A*02:01 PSMA663-671 Tetramer-MMNDQLMFL-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| MMNDQLMFL | 663-671 | ４°C | ||||
|
|
TS-M243-2 |
HLA-A*02:01 UGCGL2 Neoepitope Tetramer-GLLDEDFYA-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| GLLDEDFYA | ４°C | |||||
|
|
TS-M233-2 |
HLA-A*02:01 TEF-1 Neoepitope Tetramer-SVLENFTIFL-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| SVLENFTIFL | ４°C | |||||
|
|
TS-M215-2 |
HLA-A*02:01 WDR46 Neoepitope Tetramer-FLIYLDVSV-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| FLIYLDVSV | ４°C | |||||
|
|
TS-M233-1 |
HLA-A*02:01 TEF-1 Neoepitope Tetramer-SVLENFTIFL-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| SVLENFTIFL | ４°C | |||||
|
|
TS-M239-2 |
HLA-A*02:01 SPOP Neoepitope Tetramer-FLLDEAIGL-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| FLLDEAIGL | ４°C | |||||
|
|
TS-M237-2 |
HLA-A*02:01 GCN1 Neoepitope Tetramer-ALLETPSLLL-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| ALLETPSLLL | ４°C | |||||
|
|
TS-M232-2 |
HLA-A*02:01 MRM1 Neoepitope Tetramer-LLFGMPPCL-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| LLFGMPPCL | ４°C | |||||
- The availability is based on the information in Japan at 00:05, Jul 14, 2026 in JST.
- The special price is shown in red color.
- Please note that products cannot be ordered from this website. To purchase the items listed in this website, please contact us or local distributers.
- For storage temparature: RT: room temparature
- Please note that products in this website might be changed or discontinued without notification in advance for quality improvement.